S&P 500   2,996.31 (+0.22%)
DOW   26,997.47 (-0.02%)
QQQ   193.09 (+0.03%)
FB   189.15 (-0.21%)
MSFT   139.51 (-0.64%)
AMZN   1,786.73 (+0.52%)
CGC   20.09 (+1.82%)
NVDA   194.37 (+0.08%)
MU   45.46 (+0.66%)
BABA   176.17 (-0.54%)
GE   9.09 (+2.13%)
TSLA   261.12 (+0.53%)
AMD   31.06 (+0.81%)
T   37.70 (-0.24%)
F   9.12 (+0.55%)
PRI   123.67 (-0.16%)
NFLX   295.25 (+3.13%)
GILD   65.60 (+0.38%)
DIS   132.63 (+1.35%)
S&P 500   2,996.31 (+0.22%)
DOW   26,997.47 (-0.02%)
QQQ   193.09 (+0.03%)
FB   189.15 (-0.21%)
MSFT   139.51 (-0.64%)
AMZN   1,786.73 (+0.52%)
CGC   20.09 (+1.82%)
NVDA   194.37 (+0.08%)
MU   45.46 (+0.66%)
BABA   176.17 (-0.54%)
GE   9.09 (+2.13%)
TSLA   261.12 (+0.53%)
AMD   31.06 (+0.81%)
T   37.70 (-0.24%)
F   9.12 (+0.55%)
PRI   123.67 (-0.16%)
NFLX   295.25 (+3.13%)
GILD   65.60 (+0.38%)
DIS   132.63 (+1.35%)
Log in

Vanda Pharmaceuticals SEC Filings & 10K Form (NASDAQ:VNDA)

$13.62
+0.22 (+1.64 %)
(As of 10/17/2019 11:04 AM ET)
Today's Range
$13.46
Now: $13.62
$13.71
50-Day Range
$12.41
MA: $13.50
$14.49
52-Week Range
$11.83
Now: $13.62
$33.44
Volume66,544 shs
Average Volume584,108 shs
Market Capitalization$725.54 million
P/E Ratio28.38
Dividend YieldN/A
Beta0.32

SEC Filings

Vanda Pharmaceuticals (NASDAQ:VNDA) SEC Filings

DateFilerForm TypeView
08/28/2019
3:30 PM
DUGAN RICHARD W (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
3:52 PM
Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
3:48 PM
Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/21/2019
3:46 PM
Jones Aranthan II (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/19/2019
6:09 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2019
3:58 PM
Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
6:04 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2019
3:05 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2019
7:35 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
4:25 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2019
3:58 PM
ARMISTICE CAPITAL, LLC (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G
06/17/2019
4:03 PM
Vanda Pharmaceuticals (Issuer)
Watkins Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:03 PM
DUGAN RICHARD W (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:02 PM
COLA MICHAEL F (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:01 PM
Chrousos Phaedra (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:32 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
3:32 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2019
4:02 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
3:32 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
6:02 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2019
7:30 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2019
3:31 PM
Vanda Pharmaceuticals (Filer)
Form DEF 14A
04/24/2019
4:34 PM
Chrousos Phaedra (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2019
4:31 PM
Chrousos Phaedra (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/24/2019
3:36 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
4:06 PM
Kelly James Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
4:02 PM
Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
3:27 PM
Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
3:19 PM
Kelly James Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
3:18 PM
Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
7:30 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2019
6:02 AM
Vanda Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
1:59 PM
ARMISTICE CAPITAL, LLC (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2019
1:51 PM
MACQUARIE GROUP LTD (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2019
6:51 AM
Consonance Capital Management LP (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G
02/11/2019
9:31 AM
Vanda Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/06/2019
5:07 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
3:34 PM
Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:33 PM
Kelly James Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:31 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2018
3:31 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2018
3:32 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
4:08 PM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
3:06 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2018
3:26 PM
BlackRock Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G/A
10/04/2018
3:31 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
4:24 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
4:06 PM
Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2018
4:00 PM
Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/02/2018
6:01 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2018
3:19 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2018
3:32 PM
COLA MICHAEL F (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:31 PM
DUGAN RICHARD W (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:30 PM
MILANO VINCENT (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
3:30 PM
Vanda Pharmaceuticals (Issuer)
Watkins Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2018
3:08 PM
Vanda Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/13/2018
3:02 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2018
3:47 PM
Vanda Pharmaceuticals (Filer)
Form DEFA14A
06/01/2018
3:28 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2018
3:01 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2018
3:06 PM
Vanda Pharmaceuticals (Issuer)
Watkins Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2018
4:03 PM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2018
3:07 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2018
6:04 AM
Vanda Pharmaceuticals (Filer)
Form DEFA14A
04/27/2018
6:01 AM
Vanda Pharmaceuticals (Filer)
Form DEF 14A
04/25/2018
4:01 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2018
4:01 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2018
3:02 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2018
6:01 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2018
4:02 PM
DUGAN RICHARD W (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2018
5:06 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2018
3:13 PM
Vanda Pharmaceuticals (Filer)
Form 424B5
03/14/2018
3:09 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2018
6:16 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2018
4:37 PM
Reverberi Gian Piero (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:36 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:34 PM
Kelly James Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:33 PM
Gulino Richard L. (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2018
4:32 PM
Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2018
4:01 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2018
6:03 AM
Vanda Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2018
3:54 PM
GREAT POINT PARTNERS LLC (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2018
3:10 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2018
1:15 PM
Point72 Asset Management, L.P. (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2018
12:16 PM
MACQUARIE GROUP LTD (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G
02/14/2018
10:28 AM
ARMISTICE CAPITAL, LLC (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2018
8:00 AM
Flynn James E (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G/A
02/09/2018
10:48 AM
Vanda Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
01/08/2018
7:01 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2018
4:14 PM
Reverberi Gian Piero (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
4:13 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
4:12 PM
Kelly James Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
4:11 PM
Gulino Richard L. (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
4:09 PM
Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel